Navarro et al., 2017 - Google Patents
Enhanced probiotic potential of Lactobacillus reuteri when delivered as a biofilm on dextranomer microspheres that contain beneficial cargoNavarro et al., 2017
View HTML- Document ID
- 14581647867005859536
- Author
- Navarro J
- Mashburn-Warren L
- Bakaletz L
- Bailey M
- Goodman S
- Publication year
- Publication venue
- Frontiers in Microbiology
External Links
Snippet
As with all orally consumed probiotics, the Gram-positive bacterium Lactobacillus reuteri encounters numerous challenges as it transits through the gastrointestinal tract of the host, including low pH, effectors of the host immune system, as well as competition with …
- 241000186604 Lactobacillus reuteri 0 title abstract description 166
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Navarro et al. | Enhanced probiotic potential of Lactobacillus reuteri when delivered as a biofilm on dextranomer microspheres that contain beneficial cargo | |
| US11497780B2 (en) | Prebiotic formulations | |
| Deng et al. | Quorum sensing, biofilm, and intestinal mucosal barrier: involvement the role of probiotic | |
| Vallianou et al. | Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives | |
| Ayyanna et al. | Anti-inflammatory and antioxidant properties of probiotic bacterium Lactobacillus mucosae AN1 and Lactobacillus fermentum SNR1 in Wistar albino rats | |
| Sarita et al. | A comprehensive review of probiotics and human health-current prospective and applications | |
| Yang et al. | Lauric acid is an inhibitor of Clostridium difficile growth in vitro and reduces inflammation in a mouse infection model | |
| Wolfe et al. | The challenge of applications of probiotics in gastrointestinal diseases | |
| Mendonça et al. | Journey of the probiotic bacteria: Survival of the fittest | |
| Martín et al. | Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease | |
| Koo et al. | Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol | |
| Becker et al. | Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model | |
| Pohl | Recent advances and opportunities in the study of Candida albicans polymicrobial biofilms | |
| Bubnov et al. | Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice | |
| US20100028449A1 (en) | Fermented milk product and use thereof | |
| WO2018183355A1 (en) | Prebiotic formulations | |
| Yan et al. | Extrusion of dissolved oxygen by exopolysaccharide from Leuconostoc mesenteroides and its implications in relief of the oxygen stress | |
| Zhai et al. | Synergy between probiotic Lactobacillus casei and milk to maintain barrier integrity of intestinal epithelial cells | |
| US20210401904A1 (en) | Prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies | |
| US20210290701A1 (en) | Prenatal probiotic formulations | |
| Compare et al. | Probiotics in gastrointestinal diseases: all that glitters is not gold | |
| Wu et al. | Lactobacillus plantarum postbiotics trigger AMPK‐dependent autophagy to suppress Salmonella intracellular infection and NLRP3 inflammasome activation | |
| Akimbekov et al. | Nutritional factors influencing microbiota-mediated colonization resistance of the oral cavity: A literature review | |
| Fujiwara | Crosstalk between intestinal microbiota derived metabolites and tissues in allogeneic hematopoietic cell transplantation | |
| Sajankila et al. | Current and future methods of probiotic therapy for necrotizing enterocolitis |